tiletamine hydrochloride has been researched along with 4-butyrolactone in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (19.05) | 29.6817 |
| 2010's | 11 (52.38) | 24.3611 |
| 2020's | 6 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Carnuccio, R; D'acquisto, F; Lanzotti, V | 1 |
| Abe, N; Arakawa, T; Hirota, A; Yamamoto, K | 1 |
| Dutton, JM; Glansdorp, FG; Lee, JK; Salmond, GP; Spring, DR; Thomas, GL; Welch, M | 1 |
| Argade, NP; Baag, MM; Puranik, VG | 1 |
| Chiang, BH; Kuo, YH; Lin, YW; Liu, RH; Pan, JH; Sheen, LY | 1 |
| Chiang, BH; Lin, YW | 1 |
| Chen, KH; Chiang, BH; Chiang, CC; Huang, TN; Lin, YW | 1 |
| Chang, CH; Chang, WL; Chung, CH; Hsu, CC; Huang, TF; Ko, FN; Lin, KT; Peng, HC; Wang, SW | 1 |
| Adebayo, BO; Chang, TC; Deng, L; Hsiao, M; Huang, CC; Lee, WH; Lin, YC; Rao, YK; Tzeng, YM; Wang, LS; Wu, AT; Wu, CH; Yeh, CT | 1 |
| Bayfield, MA; Campos, ML; Eberlin, MN; Ifa, DR; Perez, C; Tata, A | 1 |
| Chang, TL; Chen, KH; Chiang, BH; Chou, KC; Lin, PY; Sheu, F; Wu, HL; Yang, SH | 1 |
| Bamodu, OA; Deng, L; Hsiao, M; Huang, CC; Huang, WC; Lee, WH; Lin, YK; Liu, M; Tzeng, YM; Wu, ATH; Yeh, CT; Yuan, CC; Zucha, MA | 1 |
| Chen, MC; Cho, TY; Kuo, YH; Lee, TH | 1 |
| Chang, CH; Chang, WL; Chung, CH; Hsu, CC; Huang, WC; Lee, AS; Lin, KT; Peng, HC; Wang, SW | 1 |
| Chiang, BH; Li, TY | 1 |
| Gerwick, L; Gerwick, WH; Glukhov, E; Lei, XL; Liu, YY; Ma, XX; Nie, YY; Yang, JM; Yang, WC; Zhang, Y | 1 |
| Lee, SY; Ou, CH; Wu, CH; Yen, IC | 1 |
| Aryandono, T; Chao, TY; Deng, L; Fong, IH; Haryana, SM; Huang, CC; Huang, WC; Lin, CC; Liu, HW; Ong, JR; Satriyo, PB; Su, CM; Tzeng, YM; Yeh, CT | 1 |
| Chang, TC; Lee, SY; Li, YF; Lin, PH; Tu, QW; Yen, IC | 1 |
| Chen, YJ; Chung, CH; Hsueh, TY; Huang, TF; Lai, YW; Lin, CC; Lin, CH; Liu, SC; Wang, SW | 1 |
| Deng, L; Jin, Y; Liu, H; Liu, J; Tzeng, YM; Wang, F; Xing, H | 1 |
21 other study(ies) available for tiletamine hydrochloride and 4-butyrolactone
| Article | Year |
|---|---|
Cyclolinteinone, a sesterterpene from sponge Cacospongia linteiformis, prevents inducible nitric oxide synthase and inducible cyclo-oxygenase protein expression by blocking nuclear factor-kappaB activation in J774 macrophages.
Topics: 4-Butyrolactone; Animals; Biological Transport; Cell Line; Cell Nucleus; Cyclohexanones; Cyclooxygenase 2; Enzyme Inhibitors; Hydrolysis; Isoenzymes; Macrophages; Mice; NF-kappa B; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Prostaglandin-Endoperoxide Synthases | 2000 |
Biosynthesis of bisorbicillinoid in Trichoderma sp. USF-2690; evidence for the biosynthetic pathway, via sorbicillinol, of sorbicillin, bisorbicillinol, bisorbibutenolide, and bisorbicillinolide.
Topics: 4-Butyrolactone; Acetylation; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Cyclohexanones; Fermentation; Magnetic Resonance Spectroscopy; Models, Molecular; Resorcinols; Trichoderma | 2002 |
Synthesis and stability of small molecule probes for Pseudomonas aeruginosa quorum sensing modulation.
Topics: 4-Butyrolactone; Biochemistry; Cyclohexanones; Drug Evaluation, Preclinical; Fluorine; Homoserine; Hydrolysis; Isomerism; Ketones; Molecular Probes; Pseudomonas aeruginosa; Serratia; Structure-Activity Relationship | 2004 |
Facile chemo-, regio-, and diastereoselective approach to cis-3,5-disubstituted gamma-butyrolactones and fused gamma-butyrolactones.
Topics: 4-Butyrolactone; Benzofurans; Cyclohexanones; Esters; Ketones; Lithium Compounds; Molecular Conformation; Stereoisomerism | 2007 |
The 4-acetylantroquinonol B isolated from mycelium of Antrodia cinnamomea inhibits proliferation of hepatoma cells.
Topics: 4-Butyrolactone; Antineoplastic Agents; Antrodia; Biological Products; Carcinoma, Hepatocellular; Cell Proliferation; Cyclohexanones; Fermentation; Hep G2 Cells; Humans; Liver Neoplasms; Mycelium | 2010 |
4-acetylantroquinonol B isolated from Antrodia cinnamomea arrests proliferation of human hepatocellular carcinoma HepG2 cell by affecting p53, p21 and p27 levels.
Topics: 4-Butyrolactone; Antineoplastic Agents; Antrodia; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclohexanones; G1 Phase; Hep G2 Cells; Humans; S Phase; Tumor Suppressor Protein p53 | 2011 |
Enhancement of 4-acetylantroquinonol B production by supplementation of its precursor during submerged fermentation of Antrodia cinnamomea.
Topics: 4-Butyrolactone; Antineoplastic Agents; Antrodia; Cell Proliferation; Culture Media; Cyclohexanones; Fermentation; Gas Chromatography-Mass Spectrometry; Hep G2 Cells; Humans | 2013 |
4-Acetylantroquinonol B suppresses tumor growth and metastasis of hepatoma cells via blockade of translation-dependent signaling pathway and VEGF production.
Topics: 4-Butyrolactone; Animals; Antineoplastic Agents; Antrodia; Carcinoma, Hepatocellular; Cell Movement; Cell Proliferation; Cyclohexanones; Down-Regulation; Hep G2 Cells; Humans; Liver Neoplasms; Male; Metatarsal Bones; Mice, Nude; Mice, SCID; Phosphorylation; Protein Biosynthesis; Signal Transduction; TOR Serine-Threonine Kinases; Vascular Endothelial Growth Factor A | 2015 |
4-Acetylantroquinonol B inhibits colorectal cancer tumorigenesis and suppresses cancer stem-like phenotype.
Topics: 4-Butyrolactone; Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cell Proliferation; Colorectal Neoplasms; Cyclohexanones; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Fluorouracil; Gene Expression Regulation, Neoplastic; HCT116 Cells; HT29 Cells; Humans; Leucovorin; Mice, Inbred NOD; Mice, SCID; Neoplastic Stem Cells; Organoplatinum Compounds; Phenotype; Signal Transduction; Spheroids, Cellular; Time Factors; Tumor Burden; Xenograft Model Antitumor Assays | 2015 |
Imprint Desorption Electrospray Ionization Mass Spectrometry Imaging for Monitoring Secondary Metabolites Production during Antagonistic Interaction of Fungi.
Topics: 4-Butyrolactone; Agaricales; Biological Products; Butanes; Coculture Techniques; Cyclohexanones; Lactones; Secondary Metabolism; Spectrometry, Mass, Electrospray Ionization; Trichoderma | 2015 |
Biosynthesis of Antroquinonol and 4-Acetylantroquinonol B via a Polyketide Pathway Using Orsellinic Acid as a Ring Precursor in Antrodia cinnamomea.
Topics: 4-Butyrolactone; Antrodia; Biosynthetic Pathways; Cyclohexanones; Fungal Proteins; Molecular Structure; Mycelium; Polyketides; Resorcinols; Ubiquinone | 2017 |
4-Acetylantroquinonol B suppresses autophagic flux and improves cisplatin sensitivity in highly aggressive epithelial cancer through the PI3K/Akt/mTOR/p70S6K signaling pathway.
Topics: 4-Butyrolactone; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; Autophagy-Related Protein 5; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Survival; Cisplatin; Cyclohexanones; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Mice, Inbred NOD; Mice, SCID; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Ribosomal Protein S6 Kinases, 70-kDa; RNA Interference; Signal Transduction; Time Factors; TOR Serine-Threonine Kinases; Transfection; Tumor Burden; Xenograft Model Antitumor Assays | 2017 |
Meroterpenoids from a Medicinal Fungus Antrodia cinnamomea.
Topics: 4-Butyrolactone; Antrodia; Cyclohexanones; Fluorouracil; Fungi; Humans; Molecular Structure; Structure-Activity Relationship; Taiwan; Terpenes; Ubiquinone | 2017 |
4-Acetylantroquinonol B inhibits lipopolysaccharide-induced cytokine release and alleviates sepsis through of MAPK and NFκB suppression.
Topics: 4-Butyrolactone; Animals; Cell Survival; Cyclohexanones; Cytokines; Lipopolysaccharides; Male; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Mitogen-Activated Protein Kinases; NF-kappa B; RAW 264.7 Cells; Sepsis | 2018 |
4-Acetylantroquinonol B from antrodia cinnamomea enhances immune function of dendritic cells against liver cancer stem cells.
Topics: 4-Butyrolactone; Animals; Antrodia; Cell Survival; Coculture Techniques; Cyclohexanones; Dendritic Cells; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Immunity, Cellular; Liver Neoplasms; Mice; Neoplastic Stem Cells; RAW 264.7 Cells | 2019 |
An anti-inflammatory isoflavone from soybean inoculated with a marine fungus
Topics: 4-Butyrolactone; Acetylcholinesterase; Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Aspergillus; Cholinesterase Inhibitors; Cyclohexanones; Free Radical Scavengers; Furocoumarins; Genistein; Glycine max; Inflammation; Isoflavones; Lipopolysaccharides; Mice; RAW 264.7 Cells | 2020 |
4-Acetylantroquinonol B Inhibits Osteoclastogenesis by Inhibiting the Autophagy Pathway in a Simulated Microgravity Model.
Topics: 4-Butyrolactone; Animals; Apoptosis; Autophagy; Cell Cycle Checkpoints; Cyclohexanones; Gene Expression Regulation; Mice; Osteoclasts; RAW 264.7 Cells; Signal Transduction; Weightlessness Simulation | 2020 |
4-Acetylantroquinonol B induced DNA damage response signaling and apoptosis via suppressing CDK2/CDK4 expression in triple negative breast cancer cells.
Topics: 4-Butyrolactone; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 4; Cyclohexanones; DNA Damage; DNA Repair; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Humans; Mice, Inbred NOD; Mice, SCID; Signal Transduction; Triple Negative Breast Neoplasms; Tumor Burden; Xenograft Model Antitumor Assays | 2021 |
4-Acetylantroquinonol B ameliorates nonalcoholic steatohepatitis by suppression of ER stress and NLRP3 inflammasome activation.
Topics: 4-Butyrolactone; Animals; Cyclohexanones; Endoplasmic Reticulum Stress; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; RAW 264.7 Cells; Receptors, Cell Surface | 2021 |
4-Acetylantroquinonol B Suppresses Prostate Cancer Growth and Angiogenesis via a VEGF/PI3K/ERK/mTOR-Dependent Signaling Pathway in Subcutaneous Xenograft and In Vivo Angiogenesis Models.
Topics: 4-Butyrolactone; Angiogenesis Inhibitors; Cell Movement; Cell Proliferation; Cell Survival; Cyclohexanones; Gene Expression Regulation, Neoplastic; Human Umbilical Vein Endothelial Cells; Humans; Male; PC-3 Cells; Phosphatidylinositol 3-Kinase; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2022 |
Application of Multiple Strategies to Improve the Production of the Potential Cancer Drug 4-Acetylantroquinonol B (4-AAQB) by the Rare Fungus Antrodia cinnamomea.
Topics: 4-Butyrolactone; Antineoplastic Agents; Cyclohexanones; Neoplasms; Polyporales | 2022 |